UMIN-CTR History
Name： UMIN ID：
| Unique ID issued by UMIN | UMIN000012536 |
|---|---|
| Receipt number | R000014522 |
| Scientific Title | Phase I study of Erlotinib with Cisplatin, Pemetrexed, and Bevacizumab for chemotherapy naive advanced non-squamous non small cell lung cancer harboring EGFR mutation |
| Date of disclosure of the study information | 2013/12/10 |
| Last modified on | 2018/06/13 09:06:25 |
| No. | Disposal | Last modified on | Item of update | |
|---|---|---|---|---|
| 1 | Insert | 2013/12/09 20:18:14 | ||
| 2 | Update | 2014/01/28 19:30:41 | Recruitment status |
|
| 3 | Update | 2014/11/04 08:57:13 | Anticipated trial start date |
|
| 4 | Update | 2015/05/21 17:57:01 | Recruitment status |
|
| 5 | Update | 2018/06/13 09:05:49 | Name of primary person or sponsor Organization |
|
| 6 | Update | 2018/06/13 09:06:25 | Recruitment status |
